Literature DB >> 732727

Intentional chloroquine overdosage.

W J Britton, I H Kevau.   

Abstract

Twenty-six episodes of intentional chloroquine overdosage are documented. The over-all mortality rate of 19%, and 50% incidence of cardiac arrest for ingestion of 2.25 g or more of chloroquine base indicate the risk of overdosage. Life-threatening cardiac arrhythmias may be the first sign of overdosage. However, gastrointestinal and neurological symptoms generally precede this sign. Early recognition and attempts to decrease drug uptake are important as current therapy after absorption of the drug is inadequate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 732727     DOI: 10.5694/j.1326-5377.1978.tb76816.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  Chloroquine overdose in Papua New Guinea.

Authors:  I Flaurenson; S Naraqi; D G Lalloo; A J Trevett; I H Kevau
Journal:  BMJ       Date:  1993-08-28

2.  Chloroquine Ingestion to Prevent SARS-CoV-2 Infection: A Report of Two Cases.

Authors:  Jonathan Graff; Michelle Geyer Thompson; Zachary Berriochoa; Bryan Kuhn; Anne-Michelle Ruha; Christopher Lipinski
Journal:  Clin Pract Cases Emerg Med       Date:  2021-05

Review 3.  Clinical features and management of poisoning due to antimalarial drugs.

Authors:  A Jaeger; P Sauder; J Kopferschmitt; F Flesch
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

4.  Amrinone for refractory cardiogenic shock following chloroquine poisoning.

Authors:  P Hantson; J L Ronveau; B De Coninck; J L Horn; P Mahieu; A Hassoun
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 5.  Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.

Authors:  Jacob A Lebin; Kathy T LeSaint
Journal:  West J Emerg Med       Date:  2020-06-03

Review 6.  Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

Authors:  Cornelis Smit; Mariska Y M Peeters; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.